Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis

Olalekan A. Uthman, Jessica F. Magidson, Steven A. Safren, Jean B. Nachega

Research output: Contribution to journalArticle

Abstract

We investigated the associations between depressive symptoms and adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV). We searched the PubMed, EMBASE and Cochrane CENTRAL databases for studies that reported an association between depression and adherence to ART as a primary or secondary outcome. We used a random-effect model to pool the risk estimates from the individual studies. The odds ratio (OR) with their 95 % CIs were used as summary estimates. Of 2861 citations, 111 studies that recruited 42,366 PLHIV met our inclusion criteria. When reported, the rate of PLHIV with depressive symptoms ranged from 12.8 to 78 % and the proportion of PLHIV who achieved good adherence (≥ 80 %) ranged from 20 to 98 %. There were no significant differences in rate of depressive symptoms in PLHIV by country income group; however, the proportion of PLHIV who achieved good adherence was significantly higher in lower-income countries (as defined in the 2012 World Bank Country Income Groups) (pooled rate=86 %) compared to higher-income countries (pooled rate=67.5 %; p

Original languageEnglish (US)
Pages (from-to)291-307
Number of pages17
JournalJoint Commission Journal on Quality and Patient Safety
Volume11
Issue number3
DOIs
StatePublished - Sep 1 2014
Externally publishedYes

Fingerprint

Meta-Analysis
HIV
Depression
Therapeutics
United Nations
PubMed
Odds Ratio
Databases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries : a systematic review and meta-analysis. / Uthman, Olalekan A.; Magidson, Jessica F.; Safren, Steven A.; Nachega, Jean B.

In: Joint Commission Journal on Quality and Patient Safety, Vol. 11, No. 3, 01.09.2014, p. 291-307.

Research output: Contribution to journalArticle

Uthman, Olalekan A. ; Magidson, Jessica F. ; Safren, Steven A. ; Nachega, Jean B. / Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries : a systematic review and meta-analysis. In: Joint Commission Journal on Quality and Patient Safety. 2014 ; Vol. 11, No. 3. pp. 291-307.
@article{f8aed36c66334e188e8859dadf2a8c10,
title = "Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis",
abstract = "We investigated the associations between depressive symptoms and adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV). We searched the PubMed, EMBASE and Cochrane CENTRAL databases for studies that reported an association between depression and adherence to ART as a primary or secondary outcome. We used a random-effect model to pool the risk estimates from the individual studies. The odds ratio (OR) with their 95 {\%} CIs were used as summary estimates. Of 2861 citations, 111 studies that recruited 42,366 PLHIV met our inclusion criteria. When reported, the rate of PLHIV with depressive symptoms ranged from 12.8 to 78 {\%} and the proportion of PLHIV who achieved good adherence (≥ 80 {\%}) ranged from 20 to 98 {\%}. There were no significant differences in rate of depressive symptoms in PLHIV by country income group; however, the proportion of PLHIV who achieved good adherence was significantly higher in lower-income countries (as defined in the 2012 World Bank Country Income Groups) (pooled rate=86 {\%}) compared to higher-income countries (pooled rate=67.5 {\%}; p",
author = "Uthman, {Olalekan A.} and Magidson, {Jessica F.} and Safren, {Steven A.} and Nachega, {Jean B.}",
year = "2014",
month = "9",
day = "1",
doi = "10.1007/s11904-014-0220-1",
language = "English (US)",
volume = "11",
pages = "291--307",
journal = "Nature Clinical Practice Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries

T2 - a systematic review and meta-analysis

AU - Uthman, Olalekan A.

AU - Magidson, Jessica F.

AU - Safren, Steven A.

AU - Nachega, Jean B.

PY - 2014/9/1

Y1 - 2014/9/1

N2 - We investigated the associations between depressive symptoms and adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV). We searched the PubMed, EMBASE and Cochrane CENTRAL databases for studies that reported an association between depression and adherence to ART as a primary or secondary outcome. We used a random-effect model to pool the risk estimates from the individual studies. The odds ratio (OR) with their 95 % CIs were used as summary estimates. Of 2861 citations, 111 studies that recruited 42,366 PLHIV met our inclusion criteria. When reported, the rate of PLHIV with depressive symptoms ranged from 12.8 to 78 % and the proportion of PLHIV who achieved good adherence (≥ 80 %) ranged from 20 to 98 %. There were no significant differences in rate of depressive symptoms in PLHIV by country income group; however, the proportion of PLHIV who achieved good adherence was significantly higher in lower-income countries (as defined in the 2012 World Bank Country Income Groups) (pooled rate=86 %) compared to higher-income countries (pooled rate=67.5 %; p

AB - We investigated the associations between depressive symptoms and adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV). We searched the PubMed, EMBASE and Cochrane CENTRAL databases for studies that reported an association between depression and adherence to ART as a primary or secondary outcome. We used a random-effect model to pool the risk estimates from the individual studies. The odds ratio (OR) with their 95 % CIs were used as summary estimates. Of 2861 citations, 111 studies that recruited 42,366 PLHIV met our inclusion criteria. When reported, the rate of PLHIV with depressive symptoms ranged from 12.8 to 78 % and the proportion of PLHIV who achieved good adherence (≥ 80 %) ranged from 20 to 98 %. There were no significant differences in rate of depressive symptoms in PLHIV by country income group; however, the proportion of PLHIV who achieved good adherence was significantly higher in lower-income countries (as defined in the 2012 World Bank Country Income Groups) (pooled rate=86 %) compared to higher-income countries (pooled rate=67.5 %; p

UR - http://www.scopus.com/inward/record.url?scp=84925548386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925548386&partnerID=8YFLogxK

U2 - 10.1007/s11904-014-0220-1

DO - 10.1007/s11904-014-0220-1

M3 - Article

C2 - 25038748

VL - 11

SP - 291

EP - 307

JO - Nature Clinical Practice Oncology

JF - Nature Clinical Practice Oncology

SN - 1759-4774

IS - 3

ER -